CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: Therapeutic Effect of Isogladine Maleate on Small Intestinal Mucosal Injury Associated With NSAIDS in Population [Phase 4]
Summary
Phase 4 clinical trial exploring the therapeutic effect of isogladine maleate on NSAIDs-associated small intestinal mucosal injury.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lee's Pharmaceutical Limited | Conditions: NSAIDs-associated Intestinal Mucosal Injury | Phase 4 | Status: UNKNOWN